Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples